Namazzi, RuthBond, CaitlinConroy, Andrea L.Datta, DibyadyutiTagoola, AbnerGoings, Michael J.Jang, Jeong HoonWare, Russell E.Opoka, RobertJohn, Chandy C.2024-07-152024-07-152024Namazzi R, Bond C, Conroy AL, et al. Hydroxyurea reduces infections in children with sickle cell anemia in Uganda. Blood. 2024;143(14):1425-1428. doi:10.1182/blood.2023021575https://hdl.handle.net/1805/42222After starting hydroxyurea treatment, Ugandan children with sickle cell anemia had 60% fewer severe or invasive infections, including malaria, bacteremia, respiratory tract infections, and gastroenteritis, than before starting hydroxyurea treatment (incidence rate ratio, 0.40 [ 95% confidence interval, 0.29-0.54 ]; P < .001 ).en-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalSickle cell anemiaAntisickling agentsHydroxyureaMalariaArticle